早期药物干预在有症状的COVID-19患者中的有效性:一项随机临床试验
Shehnoor Azhar1, Javed Akram2, Waqas Latif3
1Shehnoor Azhar (BDS, MPH) Doctoral candidate in Epidemiology and Public Health, University of Granada.
Pakistan journal of medical sciences
|June 3, 2024
概括
这项研究发现,在轻度症状患者中,口服氧化,阿兹特罗米辛或奥塞尔塔米维尔的COVID-19治疗有效性没有显著差异. 这些常见的COVID-19治疗方法没有显示出统计学上显著的益处.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 轻度症状的COVID-19患者需要有效的治疗选择.
- 氧化 (HC),阿兹特罗米 (AZ) 和奥塞尔塔米维尔 (OS) 已被用于COVID-19的研究.
- 关于这些口服药物的比较有效性的证据至关重要.
研究的目的:
- 评估单独或组合的口服氧化,阿兹特罗米和奥塞尔塔米维尔的有效性.
- 评估住院患者的治疗结果,这些患者患有轻度症状的COVID-19.
- 为了在不同治疗组中比较病毒清除率和临床改善率.
主要方法:
- 在巴基斯坦进行了一项具有适应性设计的多中心随机临床试验.
- 确诊的轻度COVID-19患者被随机分配到七个治疗组.
- 主要结局包括qRT-PCR阴性和到第七天的临床改善.
主要成果:
- 治疗组之间没有观察到有效性的统计学上显著差异.
- 29%的患者在第七天获得了qRT-PCR阴性.
- 23.5%的患者在第七天出现了临床改善,没有报告的不良事件.
结论:
- 口服抗疟疾,抗病毒或抗生素治疗没有显示出对轻度COVID-19有效性的统计学上显著差异.
- 该研究得出的结论是,这些特定的口服治疗方法对于这个患者群体没有被证明是有效的.
- 可能需要进一步的研究来确定适用于轻度COVID-19的最佳治疗方法.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
01:28Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
01:27Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
01:22Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57